首页> 外文OA文献 >In vitro expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.
【2h】

In vitro expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.

机译:体外扩增的供体同种异体抗原特异性CD4 + CD25 +调节性T细胞可促进实验性移植耐受性。

摘要

CD4(+)CD25(+) regulatory T (Treg) cells play a critical role in the induction and maintenance of peripheral immune tolerance. In experimental transplantation models in which tolerance was induced, donor-specific Treg cells could be identified that were capable of transferring the tolerant state to naive animals. Furthermore, these cells appeared to have indirect allospecificity for donor antigens. Here we show that in vivo alloresponses can be regulated by donor alloantigen-specific Treg cells selected and expanded in vitro. Using autologous dendritic cells pulsed with an allopeptide from H2-K-b, we generated and expanded T-cell lines from purified Treg cells of CBA mice (H2(k)). Compared with fresh Treg cells, the cell lines maintained their characteristic phenotype, suppressive function, and homing capacities in vivo. When cotransferred with naive CD4(+)CD25(-) effector T cells after thymectomy and T-cell depletion in CBA mice that received CBK (H2(k)+K-b) skin grafts, the expanded Treg cells preferentially accumulated in the graft-draining lymph nodes and within the graft while preventing CBK but not third-party B10.A (H2(k)+D-d) skin graft rejection. In wild-type CBA, these donor-specific Treg cells significantly delayed CBK skin graft rejection without any other immunosuppression. Taken together, these data suggest that in vitro-generated tailored Treg cells could be considered a therapeutic tool to promote donor-specific transplant tolerance. (c) 2007 by The American Society of Hematology
机译:CD4(+)CD25(+)调节性T(Treg)细胞在诱导和维持外周免疫耐受中起关键作用。在诱导耐受性的实验性移植模型中,可以鉴定出能够将耐受状态转移至幼稚动物的供体特异性Treg细胞。此外,这些细胞似乎对供体抗原具有间接的同种特异性。在这里,我们显示体内的过敏反应可以通过供体同种异体抗原特异性Treg细胞的选择和体外扩展来调节。使用来自H2-K-b的全肽脉冲的自体树突状细胞,我们从CBA小鼠(H2(k))的纯化Treg细胞生成并扩增了T细胞系。与新鲜的Treg细胞相比,该细胞系在体内保持其特征表型,抑制功能和归巢能力。当在接受CBK(H2(k)+ Kb)皮肤移植的CBA小鼠的胸腺切除术和T细胞耗竭后与幼稚CD4(+)CD25(-)效应T细胞共转移时,扩展的Treg细胞优先聚集在引流物中淋巴结和移植物内,同时防止CBK,但不能阻止第三方B10.A(H2(k)+ Dd)皮肤移植物排斥。在野生型CBA中,这些供体特异性Treg细胞可显着延迟CBK皮肤移植排斥反应,而无任何其他免疫抑制作用。综上所述,这些数据表明,体外产生的定制Treg细胞可以被认为是促进供体特异性移植耐受性的治疗工具。 (c)2007年,美国血液学会

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号